Frederick W Ahlholm
CIK 1405279 · View on SEC EDGAR ↗
Insider
First SEC filing: June 5, 2026 · Latest: June 5, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 36 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
36 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | NERV | S | 3,580 | $4.48 | $16,038 | 17,518 Direct | -16.97% | Disposed | 10.7% (price as of 2026-08-21) |
| Dec. 16, 2020 | NERV | S | 1,845 | $2.64 | $4,871 | 10,039 Direct | -15.53% | Disposed | -76.5% (price as of 2026-08-21) |
| May 26, 2020 | NERV | S 10b5-1 | 8,339 | $15.00 | $125,085 | 6,884 Direct | -54.78% | Disposed | -95.9% (price as of 2026-08-21) |
| Dec. 17, 2019 | NERV | S | 1,557 | $7.10 | $11,055 | 15,223 Direct | -9.28% | Disposed | -91.3% (price as of 2026-08-21) |
| Dec. 17, 2018 | NERV | S | 1,559 | $7.46 | $11,630 | 11,780 Direct | -11.69% | Disposed | -91.7% (price as of 2026-08-21) |
| Dec. 14, 2017 | NERV | S | 1,661 | $5.80 | $9,634 | 8,339 Direct | -16.61% | Disposed | -89.3% (price as of 2026-08-21) |
| June 1, 2017 | NERV | S 10b5-1 | 10,381 | $11.00 | $114,191 | 5,000 Direct | -67.49% | Disposed | -94.4% (price as of 2026-08-21) |
| June 1, 2017 | NERV | S 10b5-1 | 11,250 | $10.00 | $112,500 | 15,381 Direct | -42.24% | Disposed | -93.8% (price as of 2026-08-21) |
| Dec. 27, 2016 | NERV | S 10b5-1 | 17,000 | $12.51 | $212,670 | 5,000 Direct | -77.27% | Disposed | -95.0% (price as of 2026-08-21) |
| July 1, 2014 | NERV | P | 10,000 | $6.00 | $60,000 | 10,000 Direct | — | Acquired | -89.7% (price as of 2026-08-21) |
| April 20, 2011 | AMRN | S | 31,250 | $15.88 | $496,250 | 0 Direct | -100.00% | Disposed | -95.6% (price as of 2026-08-21) |
| April 4, 2011 | AMRN | S | 31,250 | $7.48 | $233,750 | 0 Direct | -100.00% | Disposed | -90.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 3, 2026 | NERV | Employee Stock Option (right to buy) | Common Stock (680,000) | $4.68 | June 2, 2036 | 680,000 | Acquired |
| Dec. 22, 2025 | NERV | Employee Stock Option (right to buy) | Common Stock (500,000) | $3.98 | Dec. 21, 2035 | 500,000 | Acquired |
| Dec. 5, 2024 | NERV | Employee Stock Option (right to buy) | Common Stock (47,500) | $2.12 | Dec. 4, 2034 | 47,500 | Acquired |
| Oct. 4, 2023 | NERV | Employee Stock Option (right to buy) | Common Stock (42,850) | $6.41 | Oct. 3, 2033 | 42,850 | Acquired |
| Dec. 13, 2022 | NERV | Employee Stock Option (right to buy) | Common Stock (26,000) | $3.11 | Dec. 12, 2032 | 26,000 | Acquired |
| Feb. 16, 2022 | NERV | Employee Stock Option (right to buy) | Common Stock (180,000) | $0.79 | Feb. 15, 2032 | 180,000 | Acquired |
| Dec. 14, 2020 | NERV | Restricted Stock Unit | Common Stock (5,000) | — | — | 5,000 | Disposed |
| Oct. 13, 2020 | NERV | Employee Stock Option (right to buy) | Common Stock (85,000) | $3.50 | Oct. 12, 2030 | 85,000 | Acquired |
| June 19, 2020 | NERV | Employee Stock Option (right to buy) | Common Stock (137,784) | $7.11 | Dec. 31, 2029 | 137,784 | Acquired |
| Dec. 31, 2019 | NERV | Employee Stock Option (right to buy) | Common Stock (37,216) | $7.11 | Dec. 30, 2029 | 37,216 | Acquired |
| Dec. 14, 2019 | NERV | Restricted Stock Unit | Common Stock (5,000) | — | — | 5,000 | Disposed |
| Dec. 14, 2018 | NERV | Restricted Stock Unit | Common Stock (5,000) | — | — | 5,000 | Disposed |
| Dec. 11, 2018 | NERV | Employee Stock Option (right to buy) | Common Stock (120,000) | $7.96 | Dec. 10, 2028 | 120,000 | Acquired |
| Dec. 14, 2017 | NERV | Restricted Stock Unit | Common Stock (5,000) | — | — | 5,000 | Disposed |
| Dec. 13, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock (120,000) | $6.10 | Dec. 13, 2027 | 120,000 | Acquired |
| June 1, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock (7,250) | $4.71 | Dec. 3, 2025 | 7,250 | Disposed |
| June 1, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock (14,381) | $5.19 | April 13, 2025 | 14,381 | Disposed |
| Dec. 27, 2016 | NERV | Employee Stock Option (Right to Buy) | Common Stock (12,000) | $4.71 | Dec. 3, 2025 | 12,000 | Disposed |
| Dec. 14, 2016 | NERV | Employee Stock Option (Right to Buy) | Common Stock (35,000) | — | Dec. 13, 2026 | 35,000 | Acquired |
| Dec. 14, 2016 | NERV | Restricted Stock Unit | Common Stock (20,000) | — | — | 20,000 | Acquired |
| Dec. 4, 2015 | NERV | Stock Option (right to buy) | Common Stock (69,000) | — | Dec. 3, 2025 | 69,000 | Acquired |
| April 14, 2015 | NERV | Stock Option (right to buy) | Common Stock (57,524) | — | April 13, 2025 | 57,524 | Acquired |
| June 30, 2014 | NERV | Employee Stock Option (Right to Buy) | Common Stock (93,541) | $6.00 | June 29, 2024 | 93,541 | Acquired |
| Feb. 1, 2012 | AMRN | Stock Option (right to buy) | Ordinary Shares [F2] (30,000) | $8.86 | Jan. 31, 2022 | 30,000 | Acquired |
| April 20, 2011 | AMRN | Stock Option (right to buy) [F1] | Ordinary Shares (31,250) | $1.70 | April 20, 2020 | 31,250 | Disposed |
| April 4, 2011 | AMRN | Stock Option (right to buy) [F1] | Ordinary Shares (31,250) | $1.70 | April 20, 2020 | 31,250 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 30, 2010 | AMRN | Stock Option (right to buy)→ Ordinary Shares [F2] (250,000) | 250,000 | Direct |